Accent Group Limited (ASX:AX1) Releases FY25 Trading Update
Accent Group Limited (ASX:AX1) releases H2 trading update, forecasting FY25 EBIT of $108-111m amid challenging market conditions.
The Hub of Australian Finance News
Accent Group Limited (ASX:AX1) releases H2 trading update, forecasting FY25 EBIT of $108-111m amid challenging market conditions.
Challenger Limited (ASX:CGF) supports APRA’s new capital settings for annuities, enhancing Australia’s retirement income market.
ASX Limited (ASX:ASX) completes the sale of its stake in Digital Asset Holdings for $57 million, recognising a pre-tax gain of $42 million in FY25.
EVE Health Group (ASX:EVE) completes acquisition of Nextract, bolstering its position in the healthcare market.
AnteoTech Ltd (ASX:ADO) reports a 130% sales increase in its Life Sciences unit and secures a significant order from the Serum Institute of India.
dorsaVi Ltd (ASX:DVL) secures an exclusive worldwide licence for advanced RRAM technology, enhancing its wearable sensors and expanding market opportunities.
Bioxyne Limited (ASX:BXN) upgrades its FY2025 revenue guidance to $28m, driven by significant growth in Australian operations and European expansion.
HITIQ Limited (ASX:HIQ) forms an exclusive global partnership with Shock Doctor to enhance concussion management through the PROTEQT instrumented mouthguard.
BetMakers Technology Group Ltd (ASX:BET) has raised A$11.5 million through a share placement to repay debt and pursue strategic acquisitions.
Geopacific Resources (ASX:GPR) reports significant high-grade gold results, extending surface mineralisation at its Woodlark Project.